USE OF MICROVESICLES IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF MEDICAL DISEASES AND CONDITIONS

The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a' subject by detecting a biomarker in microvesicles isolated from a biological, sample from the subject. Moreover, disclosed subjec...

Full description

Saved in:
Bibliographic Details
Main Authors BREAKEFIELD, XANDRA O, RUSSO, LEILEATA M, SKOG, JOHAN KARL OLOV, BROWN, DENNIS, MIRANDA, KEVIN C
Format Patent
LanguageEnglish
French
Published 12.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a' subject by detecting a biomarker in microvesicles isolated from a biological, sample from the subject. Moreover, disclosed subject matter is directed to methods of diagnosis, monitoring a disease by determining the concentration of microvesicles within a biological sample; methods of delivering a nucleic acid or protein to a target all by administering microvesicles that contain said nucleic acid or protein; methods for performing a body fluid transfusion by introducing a microvesicle-free or microvesicle enriched fluid fraction into a patient. Cette invention concerne des méthodes facilitant le diagnostic, le pronostic, la surveillance et lévaluation dune maladie ou autre affection médicale chez un sujet en détectant un biomarqueur dans des microvésicules isolées à partir dun échantillon biologique prélevé chez le sujet. Par ailleurs, linvention concerne des méthodes de diagnostic, de surveillance dune maladie en déterminant la concentration des microvésicules au sein dun échantillon biologique; des méthodes dintroduction dun acide nucléique ou dune protéine dans une cible en administrant des microvésicules contenant ledit acide nucléique ou ladite protéine; des méthodes dexécution dune transfusion de liquide organique en introduisant une fraction de liquide exempte de microvésicule ou enrichie en microvésicules chez un patient.
Bibliography:Application Number: CA20092713909